Penerbitan Berimpak Tinggi

jose de leon, georgios schoretsanitis, robert l. smith, espen molden, anssi solismaa, niko seppala, miloslav kopecek, patrik svancer, ismael olmos, carina ricciardi, celso iglesias-garcia, ana iglesias-alonso, edoardo spina, shamin mohd saffian et al..  (2022).  an international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, crp, and clozapine levels.  - pharmacopsychiatry.  73-86. 

fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

vivisana sothivelr, mohammad y. hasan, shamin m. saffian, satirah zainalabidin, azizah ugusman, mohd k. mahadi.  (2022).  revisiting mirna-21 as therapeutic strategy for myocardial infarction: a systematic review.  - journal of cardiovascular pharmacology.  393-406. 

sareneya dashni rajahthurai, muhammad junaid farrukh, mohd makmor-bakry, hui jan tan, omotayo fatokun, shamin mohd saffian and diana laila ramatillah.  (2022).  use of complementary and alternative medicine and adherence to medication therapy among stroke patients: a meta-analysis and systematic review.  - frontiers in pharmacology.  1-15. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  clinical profile and predictors of 30-day all-cause mortality of stelevation myocardial infarction (stemi) patients receiving fibrinolytic therapy in an asian population.  - heart & lung.  68-76. 

fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

jian lynn lee, shamin mohd saffian, mohd makmor-bakry, farida islahudin, hamidah alias, lokman mohd noh, intan hakimah ismail, noraida mohamed shah.  (2021).  population pharmacokinetic modelling of intravenous immunoglobulin in patients with predominantly antibody deficiencies.  - british journal of clinical pharmacology.  2956-2966. 

jian lynn lee, noraida mohamed shah, mohd makmor-bakry, farida islahudin, hamidah alias, shamin mohd saffian.  (2021).  a systematic review of population pharmacokinetic analyses of polyclonal immunoglobulin g therapy.  - international immunopharmacology.  1-11. 

nor asyikin mohd tahir, shamin mohd saffian, farida hanim islahudin, abdul halim abdul gafor, mohd makmor-bakry.  (2020).  a meta-analysis on the performance of cystatin c- versus creatinine-based egfr equations in predicting vancomycin clearance.  - journal of korean medical sciences.  1-17. 

jian lynn lee, noraida mohamed shah, mohd makmor-bakry, farida hanim islahudin, hamidah alias, lokman mohd noh, shamin mohd saffian.  (2020).  a systematic review and meta-regression analysis on the impact of increasing igg trough level on infection rates in primary immunodeficiency patients on intravenous igg therapy.  - journal of clinical immunology.  682-698. 

jiah ning tan, shamin mohd saffian, fhataheya buang, zakiah jubri, ibrahim jantan, khairana husain, norsyahida mohd fauzi.  (2020).  antioxidant and anti-inflammatory effects of genus gynura: a systematic review.  - frontiers in pharmacology.  1-29. 

shamin mohd saffian, stephen brent duffull, daniel frank broughton wright.  (2017).  warfarin dosing algorithms underpredict dose requirements in patients requiring 7 mg daily: a systematic review and meta-analysis.  - clinical pharmacology and therapeutics.  297-304. 

saffian s.m., zhang m., leong chin p.k., jensen b.p..  (2015).  quantification of dabigatran and indirect quantification of dabigatran acylglucuronides in human plasma by lc-ms/ms.  - bioanalysis.  957-966. 

saffian s.m., wright d.f.b., roberts r.l., duffull s.b..  (2015).  methods for predicting warfarin dose requirements.  - therapeutic drug monitoring.  531-538.